- Home
- CVAC vs XIFR Comparison
CVAC vs XIFR Comparison
Compare CVAC & XIFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- XIFR
- Stock Information
- Founded
- CVAC 2000
- XIFR 2014
- Country
- CVAC Germany
- XIFR United States
- Employees
- CVAC N/A
- XIFR N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- XIFR
- Sector
- CVAC Health Care
- XIFR
- Exchange
- CVAC Nasdaq
- XIFR NYSE
- Market Cap
- CVAC 764.4M
- XIFR 815.0M
- IPO Year
- CVAC 2020
- XIFR N/A
- Fundamental
- Price
- CVAC $5.40
- XIFR $8.78
- Analyst Decision
- CVAC Hold
- XIFR Sell
- Analyst Count
- CVAC 3
- XIFR 3
- Target Price
- CVAC $6.83
- XIFR $9.00
- AVG Volume (30 Days)
- CVAC 2.1M
- XIFR 945.9K
- Earning Date
- CVAC 08-14-2025
- XIFR 07-23-2025
- Dividend Yield
- CVAC N/A
- XIFR 20.77%
- EPS Growth
- CVAC N/A
- XIFR N/A
- EPS
- CVAC 0.87
- XIFR N/A
- Revenue
- CVAC $566,039,775.00
- XIFR $1,255,000,000.00
- Revenue This Year
- CVAC N/A
- XIFR $11.14
- Revenue Next Year
- CVAC $24.04
- XIFR $2.34
- P/E Ratio
- CVAC $6.22
- XIFR N/A
- Revenue Growth
- CVAC 787.60
- XIFR 15.14
- 52 Week Low
- CVAC $2.37
- XIFR $7.53
- 52 Week High
- CVAC $5.72
- XIFR $29.03
- Technical
- Relative Strength Index (RSI)
- CVAC 64.78
- XIFR N/A
- Support Level
- CVAC $5.33
- XIFR N/A
- Resistance Level
- CVAC $5.58
- XIFR N/A
- Average True Range (ATR)
- CVAC 0.12
- XIFR 0.00
- MACD
- CVAC -0.04
- XIFR 0.00
- Stochastic Oscillator
- CVAC 23.81
- XIFR 0.00
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About XIFR XPLR INFRASTRUCTURE LP
XPLR Infrastructure LP is formed to acquire, manage, and own contracted clean energy projects. It owns interests in wind and solar projects in North America, as well as natural gas infrastructure assets in Texas. Renewable energy assets consist of wind, solar, and solar-plus-storage projects and a stand-alone battery storage project, as well as contracted natural gas pipeline assets. Renewable energy sales generate maximum revenue for the company.